Similar articles

• Immune cells, pancreas development, regeneration and type 1 diabetes.

  Homo-Delarche F, Drexhage HA. Homo-Delarche F, et al. Trends Immunol. 2004 May;25(5):222-9. doi: 10.1016/j.it.2004.02.012. Trends Immunol. 2004. PMID: 15099561 Review. No abstract available.
• Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts.

  Tydén G, Reinholt FP, Sundkvist G, Bolinder J. Tydén G, et al. N Engl J Med. 1996 Sep 19;335(12):860-3. doi: 10.1056/NEJM199609193351205. N Engl J Med. 1996. PMID: 8778604 No abstract available.
• Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.

  Leijon K, Hillörn V, Bergqvist I, Holmberg D. Leijon K, et al. J Autoimmun. 1995 Jun;8(3):347-56. doi: 10.1006/jaut.1995.0027. J Autoimmun. 1995. PMID: 7575996
• IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.

  Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL. Cameron MJ, et al. J Immunol. 1997 Nov 15;159(10):4686-92. J Immunol. 1997. PMID: 9366391
• Hyperexpression of GAD in the islets may be relevant but is it sufficient to induce autoimmune insulitis?

  Pozzilli P, Leslie RD. Pozzilli P, et al. Diabetologia. 1997 Mar;40(3):357-61. doi: 10.1007/s001250050688. Diabetologia. 1997. PMID: 9084978 Review. No abstract available.